Research article · 2016
Review articlePublished 13 Jul 2016
Surrogate end points: when should they be used?
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Surrogate end point evaluation has received a lot of attention for approximately a quarter of a century. Throughout this time, the topic has been surrounded with both hopes and perils. The history of the evaluation of surrogate end point evaluation is described, from Prentice’s definition, via single-trial evaluation to meta-analytic approaches. While based on technical developments and advances in statistical methodology, the treatment of the topic here is largely nontechnical. A perspective is given as to what might be a sensible way forward. It is clear that statistical evaluation can offer a contribution to the discussion as to whether a surrogate will be adopted and in what form, but can never be seen as the sole decision maker. While there is room for the adoption of surrogates, it is very important that pitfalls and drawbacks be kept in mind at all times.
Keywords
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 24 Apr 2017
The use of surrogate end points in pulmonary arterial hypertension: Enhancing clinical decision making by improving time to clinical worsening observations
Conference abstract · 6 Apr 2018
Corneal confocal microscopy: An imaging surrogate end point for mild cognitive impairment and dementia
Review article · Apr 2006
Assessment of structure-modifying drugs in osteoarthritis: surrogate or hard clinical end points?
Conference abstract
Regulatory considerations for clinical aspects of ocular drug development - established and surrogate end-points
More from this journal
The newest in Clinical Investigation.
Article · 30 Apr 2025
Vaccine Clinical Trials: Ensuring Safety, Immunity, and Public Health Protection
Article · 30 Apr 2025
Safety and Toxicity Assessment in Clinical Research: Ensuring Patient Protection and Drug Reliability
Article · 30 Apr 2025
Regulatory Compliance (FDA, EMA, CDSCO) in Drug Efficacy Studies: Ensuring Global Standards in Clinical Research
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Investigation
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Geert Molenberghs”
- BylineArticles whose byline prints “Ariel Alonso Abad”
- BylineArticles whose byline prints “Wim van der Elst”
- BylineArticles whose byline prints “Tomasz Burzykowski”
- BylineArticles whose byline prints “Marc Buyse”
